Fund profile / Canada

Lumira Ventures Fund V

Geography: Canada
Stage: Series A
Fund size: $200M
Focus: Biotech, Digital Health and Therapeutics
Signals: Published

N°01 / About

About Lumira Ventures Fund V

Lumira Ventures hits first close on US$200M Fund V to champion North American healthcare innovation. Invests in healthcare, biotech, and digital health companies at Series A and B.

N°02 / Thesis

Investment Focus

Location / RegionCanada

Funding StageSeries A

Industry Focus

Biotech

Digital Health

Therapeutics

Investor Signals Profile

active

Sweet Spot

Pre-commercial biotech/medtech founder in underserved NA market

biotech

medtech

oncology

AI-powered drug development

North America secondary markets

rare disease

radiopharmaceuticals / autoimmune

neuromodulation / chronic pain

Bullish Signals

First close done, $52M deal deployedblog

7 exits >$8B since 2024blog

Anchor LP Northleaf returningblog

Structured succession, next-gen team builtblog

Fusion Pharma exit $2.4B AstraZenecatwitter

Co-led $105M Series A, COUR Pharmatwitter

Portfolio FDA approvals: Cordella, X4, Histosonicstwitter

Suman Rao promoted Principal Jan 2025twitter

Fund V first deal: Nervonik $52.5M Series Blinkedin

Neuromodulation/chronic pain added to thesislinkedin

Top-decile active life sciences investor last 12 monthslinkedin

Active board building at portfolio companieslinkedin

Venture Innovation Program recruiting top talentlinkedin

Cancer Breakthrough Fund invests Altis Labs oncology AIlinkedin

Nikhil Thatte leading dedicated oncology/AI investmentslinkedin

Contrarian Signals

26% of fund in single dealblog

Canadian commercialization path lags USblog

First investment undisclosed — limited transparencyblog

Large syndicate rounds — smaller ownership stakestwitter

Founder Do's

Build in secondary NA markets (not Boston/SF/NY)

Be pre-commercial with strong clinical data

Have clear strategic acquirer landscape

Show capital efficiency discipline

Target rare disease, autoimmune, neuromodulation, or oncology

Founder Don'ts

Expect passive capital — board-level engagement standard

Pitch without regulatory pathway clarity

Assume coastal-only fund coverage

32 signals on Lumira Ventures Fund V

15 bullish · 4 contrarian · 5 pitch do's · 3 don'ts · 5 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size$200M

Saves0

Website

People

Key People

Peter van der Velden

Gerry BrunkManaging Partner

Peter van der VeldenExecutive Chairman

Isabelle HarrisAssociate

Suman RaoPrincipal

Nikhil ThattePartner

Backers

Known LPs

Northleaf Capital PartnersFund-of-Funds

Fonds de solidarite FTQPension fund

N°04 / See also

Related Funds

Alphi Capital I

Fund sizeC$295M

Location: Canada
Stage: Series A
Focus: Saas
Manager: Thecla Sweeney, Andrew Fortier

Series A

Saas

Storytime Capital Fund II

Fund sizeC$14M

Location: Canada
Stage: Pre Seed
Focus: Consumer Commerce, Saas
Manager: Neil Grunberg, Ryan Kimel, Lauren Epstein

Pre Seed

Consumer Commerce

Saas

Telegraph Ventures I

Fund size$35M

Location: Canada
Stage: Pre Seed
Focus: Developer Tools, Ai Ml, Saas, Enterprise Software
Manager: Réal Cloutier, Jean-François Gagné

Pre Seed

Developer Tools

Ai Ml

Saas

Enterprise Software